Body Vision Medical

Company Overview

Snapshot

Founded in April 2014 by Dorian Averbuch, Body Vision Medical operates with 11–50 employees. The company has raised $35.42M across 5 funding rounds from 9 investors. In June 2022, David Webster was appointed as the new CEO of Body Vision Medical.

Business overview

Body Vision Medical is a medical device company specializing in augmented real-time imaging. The company has developed the Body Vision Solution, a software-driven intra-body navigation platform designed to integrate into existing operating room procedures. This platform provides accurate, real-time visualization, navigation, and tools to access soft-tissue targets, such as early-stage cancerous lesions, during diagnostic and treatment procedures. Body Vision Medical's technology enables reliable diagnostic and treatment procedures for radiolucent soft-tissue lesions, serving the healthcare industry with a focus on oncology and diagnostics.

Strategic signal

In November 2021, Body Vision Medical celebrated a significant milestone, with its AI-driven lung cancer diagnostics imaging benefiting its 1,000th patient. This achievement signals strong clinical adoption and validation of their technology, demonstrating its impact on patient care and its potential for broader market penetration in the lung cancer diagnostics space.

Company Intelligence Q&A

What is Body Vision Medical's core technology?

Body Vision Medical's core technology is the Body Vision Solution, a software-driven intra-body navigation platform that provides augmented real-time imaging for accurate visualization and navigation during diagnostic and treatment procedures for soft-tissue targets.

When did Body Vision Medical receive FDA clearance for its LungVision System?

Body Vision Medical received FDA clearance for its LungVision Navigation System in May 2017. This was a key regulatory milestone for their lung cancer detection and treatment technology.

What was a significant product update for the LungVision platform?

In May 2019, Body Vision Medical received FDA clearance to market the LungVision 2.0 System, an advancement within its LungVision Platform, enhancing its capabilities for lung cancer diagnostics.

Who was recently appointed as CEO of Body Vision Medical?

In June 2022, David Webster was appointed as the new CEO of Body Vision Medical, signaling a leadership transition for the company.

What was a notable achievement regarding patient impact for Body Vision Medical?

In November 2021, Body Vision Medical announced that its AI-driven lung cancer diagnostics imaging had benefited its 1,000th patient, highlighting the growing adoption and impact of its technology.